Add time:08/16/2019         Source:sciencedirect.com

Rationale and Objectives.A biodegradable radiopaque particulate contrast agent formulated from cyclic carbonate of ioxilan (IXC), which is a prodrug of nonionic water-soluble contrast ioxilan, recently has been developed. This contrast agent enhances liver attenuation and is cleared from the body as ioxilan. In the current study, we tested whether the biodistribution of IXC particles would be affected by the characteristics of particles.

We also recommend Trading Suppliers and Manufacturers of IOXILAN (400 MG) (cas 107793-72-6). Pls Click Website Link as below: cas 107793-72-6 suppliers